We have recently observed that the acute administration of barbiturates produces a marked reduction in cyclic guanosine monophosphate (cyclic GMP) levels in the rat cerebellum. Following long term barbital treatment, cerebellar cyclic GMP levels are only slightly reduced in the presence of acutely anesthetic concentrations of barbital in the cerebellum and in the blood. Upon abrupt barbital withdrawal cyclic GMP levels in the cerebellum are elevated 2-3 fold at a time coincident with the peak in the number of spontaneous convulsions associated with the barbital abstinence syndrome. These data provide strong evidence for the development of tolerance to barbital and for a marked post withdrawal response of cerebellar cyclic GMP. It is hypothesized that the post withdrawal elevations of cyclic GMP in the cerebellum and in other brain areas to be studied are functionally involved in the enhanced excitation associated with the barbital abstinence syndrome. In particular, elevated cerebellar cyclic GMP may be involved in the tonic-extension phase of abstinence convulsions. Cyclic GMP levels in the cerebellum are regulated by [1] extrinsic excitatory inputs which are believed to utilize excitatory amino acids, e.g., glutamate and aspartate, or acetylcholine (ACh) as neurotransmitters and [2] GABAergic cerebellar interneurons. Our recent data suggest that the GABA neurons are of lesser importance. It is therefore hypothesized that the acute and chronic effects of barbiturates on cerebellar cyclic GMP may be mediated via actions on these excitatory amino acid and/or ACh pathways. Since the basic neuronal circuitry as well as the transmitters involved is better understood in the cerebellum as opposed to other brain areas, the cerebellum is proposed as a model to investigate the adaptations of and the functional involvement of the above excitatory transmitters in barbiturate dependence and the manifestation of the abstinence syndrome. Possible presynaptic changes in transmitter synthesis and release and postsynaptic adaptations in receptors will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA000755-12
Application #
3206819
Study Section
(SRC)
Project Start
1974-06-28
Project End
1987-07-31
Budget Start
1986-09-01
Budget End
1987-07-31
Support Year
12
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
School of Medicine & Dentistry
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Morgan, W W; Bermudez, J; Chang, X Y (1991) The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells. Eur J Pharmacol 204:335-8
McCaslin, P P; Morgan, W W (1989) Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats. Eur J Pharmacol 173:127-32
McCaslin, P P; Morgan, W W (1988) Anticonvulsive activity of several excitatory amino acid antagonists against barbital withdrawal-induced spontaneous convulsions. Eur J Pharmacol 147:381-6
McCaslin, P P; Morgan, W W (1987) Activity-induced elevation of cerebellar cyclic GMP occurs in the absence of climbing fiber pathways. Brain Res 414:381-4
Bartke, A; Morgan, W W; Clayton, R N et al. (1987) Neuroendocrine studies in hyperprolactinaemic male mice. J Endocrinol 112:215-20
Brainard, G C; Morgan, W W (1987) Light-induced stimulation of retinal dopamine: a dose-response relationship. Brain Res 424:199-203
McCaslin, P P; Morgan, W W (1987) Cultured cerebellar cells as an in vitro model of excitatory amino acid receptor function. Brain Res 417:380-4
McCaslin, P P; Morgan, W W (1987) 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats. Neuropharmacology 26:731-5
King, T S; Steger, R W; Morgan, W W (1986) Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Neuroendocrinology 42:344-50
Morgan, W W; King, T S (1986) Monoamine biosynthesis in hypothalamic regions of dwarf mice: effect of replacement of deficient anterior pituitary hormones. Neuroendocrinology 42:351-6

Showing the most recent 10 out of 20 publications